Table 1 Tumor characteristics and pelvic treatment summary for 12 patients with gynecologic tumors who received a CRT boost
Patient | Primary Site | FIGO Stage | Pelvic Technique | Posterior Pelvic Attenuator 1 | PA RT | Pelvic Dose 2 | Concurrent Chemotherapy 3 |
|---|---|---|---|---|---|---|---|
1 | Vagina | 3 | POP | N | Y | 50 | N |
2 | Vagina | 1 | 4FB | N | N | 50 | Y |
3 | Cervix | 2B | 4FB | Y | N | 50 | Y |
4 | Cervix | 3B | POP | N | N | 50 | Y |
5 | Cervix | 2B | 4FB | N | N | 45 | Y |
6 | Cervix | 2B | 4FB | Y | N | 50 | Y |
7 | Cervix | 1B | 4FB | Y | N | 45 | N |
8 | Cervix | 2B | 4FB | Y | N | 45 | Y |
9 | Cervix | 4A | 4FB | N | N | 45 | N |
10 | Uterus | 3A | 4FB | N | N | 45 | Y |
11 | Uterus | Recurrent | 4FB | N | N | 45 | N |
12 | Cervix | 2B | 4FB | N | N | 45 | Y |